To contract or not: A key question for the uterine muscles in pregnancy

Nov 20, 2008

During pregnancy, the muscles of the uterus are relatively inactive. A switch to an activated state capable of strong contractions is therefore essential prior to the onset of labor. Kathleen Martin and colleagues, at Dartmouth Medical School, Lebanon, have now provided new insight into the events that prime the uterine muscles for contraction, something that they hope might have implications for the development of therapies for preterm labor (i.e., labor that occurs before 37 weeks of pregnancy), the most serious complication of pregnancy in developed countries.

In the study, when the protein IP on the surface of muscle cells in human uterine tissue strips obtained from pregnant women undergoing Caesarean delivery prior to the onset of natural labor was stimulated by agonist chemicals, it induced the upregulation of proteins involved in muscle contraction.

Further, the same chemicals increased the contraction of these tissue strips in response to the hormone oxytocin. The authors therefore conclude that the molecule that normally binds IP in vivo, prostacyclin, primes the muscles in the human uterus, allowing for strong contractions during labor.

As Michael Taggart, at Newcastle University, United Kingdom, and colleagues discuss in an accompanying commentary, these data might be viewed by many as contentious, because prostacyclin is a smooth muscle relaxant. However, they do provide an explanation for the paradoxical observation that one of the major signaling molecules produced by the uterus just prior to labor is prostacyclin.

Source: Journal of Clinical Investigation

Explore further: Errata frequently seen in medical literature

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Errata frequently seen in medical literature

19 hours ago

(HealthDay)—Errata, including those that may materially change the interpretation of data, are frequent in medical publications, according to a study published in the August issue of The American Journal of ...

Seven US-based researchers share $1.3M eyesight prize

Sep 10, 2014

Seven U.S.-based researchers are sharing a €1 million ($1.3 million) prize from a Portuguese foundation for their work developing treatment for angiogenic diseases of the retina, the leading cause of blindness in the developed ...

User comments : 0